Category: Latest News
-
TScan Therapeutics Cuts Workforce by 75% and Shifts Focus to Solid Tumor Program
TScan Therapeutics (NASDAQ:TCRX) announced a strategic reorganization that includes a workforce reduction of approximately 75% as the company redirects resources toward an in vivo-engineered T cell receptor, or TCR-T, program targeting solid tumors. The Waltham, Massachusetts-based company plans to advance two product candidates into investigational new drug-enabling studies. One candidate targets PRAME and the other…
-
BW LPG Shares Fall 5.4% After $300 Million Convertible Bond Offering
BW LPG Limited (NYSE:BWLP) shares fell 5.4% on Wednesday after the company announced the placement of $300 million in senior unsecured convertible bonds due in 2031. The bonds can be converted into new BW LPG shares, with proceeds from the offering expected to be used partly to finance the company’s newbuild programme with Hyundai Heavy…
-
FuelCell Energy Shares Fall 9.3% Premarket After Quarterly Results Miss Estimates
FuelCell Energy (NASDAQ:FCEL) shares fell 9.3% in premarket trading after the company reported fiscal third-quarter 2026 revenue and earnings per share below analyst expectations. Revenue declined 29% year over year to $33.0 million from $46.7 million in the corresponding period a year earlier. The reported figure compared with an analyst consensus estimate of approximately $40…
-
Sprinklr Shares Fall 2.4% Premarket After Quarterly Revenue Misses Estimates
Sprinklr (NYSE:CMX) shares fell 2.4% to $7.42 in premarket trading after the company reported fiscal second-quarter 2027 results, including revenue below analyst expectations. Total revenue for the quarter was $213.7 million, compared with an analyst consensus estimate of approximately $215.6 million. The reported figure was also below the company’s previous guidance range, according to the…
-
Ollie’s Bargain Outlet Shares Rise 2.3% After Quarterly Earnings Exceed Estimates
Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) shares rose 2.3% in premarket trading after the off-price retailer reported fiscal second-quarter 2026 results, including higher net sales and adjusted earnings per share. Net sales increased 9.1% year over year, while adjusted net income per diluted share rose 43.4% to $1.42. The supplied information cites a consensus earnings…
-
Hewlett Packard Enterprise Shares Rise 4.7% Ahead of Fiscal Q3 Results
Hewlett Packard Enterprise (NYSE:HPE) shares rose 4.7% to $53.28 in premarket trading on Wednesday ahead of the company’s fiscal third-quarter 2026 earnings report, scheduled for release after the market close. The stock had closed the previous session at $50.87. The move also followed recent analyst actions and quarterly results from Dell, another company with exposure…
-
NurExone Biologic progresses towards a new regenerative therapy and sets sights on a potential NASDAQ listing
Can exosomes become both the foundation of a new regenerative therapy and a commercial business in their own right? Hello, I’m Ricki Lee, and this is another episode of The Capital Compass. Today, we’re checking back in with NurExone Biologic (USOTC:NRXBF) (TSXV:NRX), a biotech company developing exosome-based therapies for central nervous system injuries. Alongside its…
-
Universe Pharmaceuticals Shares Rise 22.6% Premarket With No New Catalyst Identified
Universe Pharmaceuticals Inc (NASDAQ:UPC) shares rose 22.6% to $5.23 in premarket trading, with no new company press release, financial results or analyst action identified in the supplied information as an immediate catalyst for the move. The increase follows periods of substantial share-price volatility for the pharmaceutical company during 2026. Without a specific same-day development, the…
-
Sirius XM Shares Rise 3.1% Premarket After Deutsche Bank Upgrade
Sirius XM (NASDAQ:SIRI) shares rose 3.1% in premarket trading after Deutsche Bank upgraded the stock to Buy from Hold and increased its price target to $45 from $31. The brokerage’s revised target represents its assessment of the stock’s potential value and is not an established future share price. Before the upgrade, the supplied information showed…
-
Aligos Therapeutics Shares Rise 7.6% Premarket Following Recent Company Updates
Aligos Therapeutics (NASDAQ:ALGS) shares rose 7.6% to $6.55 in premarket trading, with no specific company announcement identified in the supplied information as an immediate catalyst for the move. The increase came as the broader U.S. equity market traded lower. Recent developments at the clinical-stage biotechnology company have included its second-quarter 2026 financial results and an…